COVID-19 vaccination in immunocompromised patients

Covid-19 Vaccination and Reactivation of Varicella Zoster Virus

Introduction: After COVID-19 pandemic in 2020 that mostly affects upper respiratory tract, the scientists investigated an effective vaccine against the virus. As the vaccination of general population started some patients were visited with varicella zoster virus activation following the COVID vaccine.

Promote COVID-19 vaccination uptake: a letter to editor

The evaluation of COVID-19 vaccination program in Duhok province, Iraqi Kurdistan: challenges and solutions

The aim of this review is to evaluate the COVID-19 vaccination program in Duhok, determining negative and positive points, subsequently improving it. In Duhok,, across the 59 mass vaccination centers, vaccination coverage rates were investigated for all population aged  ≥ 18 years and population aged ≥ 12 years receiving the three available vaccines, namely: Sinopharm, AstraZeneca, and Pfizer b...

COVID-19 and its Outcomes in Multiple Sclerosis Patients

Background: Coronavirus Disease 2019 (COVID-19) is a highly contagious disease that resulted in 4533645 deaths until September first, 2021. Multiple Sclerosis (MS) patients receive immunosuppressive drugs. Thus, there is a concern that these drugs will reduce the patient’s immune system resistance against COVID19. Objectives: This study aimed to evaluate the epidemiology of COVID19 and its ...

Varicella vaccination of immunocompromised children.

BACKGROUND Exposure of immunocompromised children to varicella often requires postexposure prophylaxis. Exposures requiring this management are often not recognized. Varicella can be a severe disease when it occurs in immunocompromised children, in spite of antiviral therapy. Varicella exposure and varicella in these children can also disrupt scheduled therapy for their underlying illness. Both...